Literature DB >> 3571047

Minor synergy and antagonism may be clinically important.

M C Berenbaum.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3571047     DOI： 10.1093/jac/19.2.271

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs.

Authors:  Timothy M E Davis; Juliana Hamzah; Kenneth F Ilett; Harin A Karunajeewa; John C Reeder; Kevin T Batty; Sara Hackett; P Hugh R Barrett
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.

Authors:  Joseph Meletiadis; Spyros Pournaras; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

3.  Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.

Authors:  Julien M Buyck; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.

Authors:  N Desbiolles; L Piroth; C Lequeu; C Neuwirth; H Portier; P Chavanet
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  In vitro synergism of rifampin-cephalosporin combinations against Haemophilus influenzae type b.

Authors:  R C Gordon; R Wofford-McQueen; K Shu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

6.  Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection.

Authors:  D M MacCallum; A P Desbois; P J Coote
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-10       Impact factor: 3.267
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.